The authors have recently noticed that the published version of this article contained errors in [Figs. 1](#fig0001){ref-type="fig"}e and [7](#fig0002){ref-type="fig"}e. These errors were inadvertently caused during the assembly of the western blot images due to our negligence. The corrected [Figs. 1](#fig0001){ref-type="fig"} and [7](#fig0002){ref-type="fig"} are given below. This correction has not changed the description, interpretation, or the original conclusions of the manuscript. The authors apologize for any inconvenience caused.Fig. 1**circHIPK2 is involved in the differentiation of NSCs.** (a) qPCR analysis of circHIPK2 expression in NSCs cultured for 1, 7, and 14 d in differentiation medium. All data were presented as mean ± SEM of 3 independent experiments. \**P* \< 0.05, \*\**P* \< 0.01 vs the 1 d one-way ANOVA followed by Holm-Sidak *post hoc* multiple comparison test. (b) qPCR confirmed that circHIPK2 siRNA lentivirus-transducted NSCs successfully decreased circHIPK2 expression. All data were presented as mean ± SEM of 3 independent experiments. \*\*\**P* \< 0.001 vs the circCon siRNA group using Student\'s *t*-test. (c-d) Representative image of BrdU immunostaining (c) and quantification of BrdU immunofluorescence-positive cell numbers (d). All data were presented as mean ± SEM of 3 independent experiments. (e-f) Western blot analysis showing GFAP (astrocyte marker) and TUJ1 (neuronal marker) protein expression in the si-circCon-NSC group and in the si-circHIPK2-NSC group. All data were presented as mean ± SEM of 3 independent experiments. \*\**P* \< 0.01 vs the si-circCon-NSCs using two-way ANOVA followed by Holm-Sidak *post hoc* multiple comparison test. (g--j) Representative immunostaining of GFAP^+^ (g) or TUJ1^+^ (i) cells from differentiated NSCs with si-circHIPK2 lentivirus transduction. Scale bar = 50 μm. Quantification of GFAP^+^ (h) or TUJ1^+^ (j) cell numbers using ImageJ software. Timescale indicates days after NSC differentiation. All data were presented as mean ± SEM of 3 independent experiments. \**P* \< 0.05, \*\**P* \< 0.01 vs the si-circCon-NSC group cultured in differentiation medium for 7 and 14 d using two-way ANOVA followed by Holm-Sidak *post hoc* multiple comparison test.Fig 1Fig. 7**Silencing of circHIPK2 promotes NSC differentiation via Smox.** (a) Heatmap assessing the variations in mRNA expression between the si-circCon-NSC group and the si-circHIPK2-NSC group. *n* = 3 per group. \**P* \< 0.05 vs the si-circCon-NSC group. (b) The level of Smox mRNA in circHIPK2 siRNA transduced NSCs analysed by qPCR. All data were presented as mean ± SEM of 3 independent experiments. \*\*\**P* \< 0.001 vs the circCon siRNA group using Student\'s *t*-test. (c-d) Western blot analysis of Smox expression in circHIPK2 siRNA transduced NSCs. All data were presented as mean ± SEM of 3 independent experiments. \*\*\**P* \< 0.001 vs the circCon siRNA group using Student\'s *t*-test. (e-f) circHIPK2 siRNA attenuated the expression of OGD/R-induced Smox expression in NSCs, as determined by western blot analysis. NSCs were treated with OGD for 2 h and reperfused for 6 h. All data were presented as mean ± SEM of 3 independent experiments. \*\**P* \< 0.01, \*\*\**P* \< 0.001 vs the control si-circCon group; ^\#^*P* \< 0.05 vs the OGD/R-treated si-circCon group using two-way ANOVA followed by Holm-Sidak *post hoc* multiple-comparison tests. (g-h) Western blot analysis of Smox expression in tMCAO mice injected with si-circCon-NSCs and si-circHIPK2-NSCs. *n* = 6 per group. \*\**P* \< 0.01, \*\*\**P* \< 0.001 vs the sham group; **^\#\#^***P* \< 0.01 vs the si-circCon-NSC group using two-way ANOVA followed by Holm-Sidak *post hoc* multiple-comparison tests. (i) qPCR analysis of Smox mRNA in the si-Con-NSC group and si-Smox-NSC group. All data were presented as mean ± SEM of 3 independent experiments. \*\*\**P* \< 0.001 vs the si-Con-NSC group. (j-k) Smox siRNA attenuated the expression of OGD/R-induced TUJ1 in NSCs determined by western blot. All data were presented as mean ± SEM of 3 independent experiments. \*\*\**P* \< 0.001 vs the si-Con-NSC group; ^\#\#^*P* \< 0.01 vs the OGD/R si-Con group using two-way ANOVA followed by Holm-Sidak *post hoc* multiple-comparison tests.Fig 7
